SCA Pharmaceuticals, LLC has recalled 1,363 syringes of Lidocaine HCl 2% (5 mL), a prescription local anesthetic. The recall was initiated after foreign material was discovered inside the vial during manufacturing. Using an injectable medication that contains unidentified particles can lead to serious health complications, such as inflammation or infection at the injection site. These products were distributed to healthcare facilities nationwide.
The presence of a foreign substance in a sterile injectable drug poses a significant health risk. If injected, the particles could cause local tissue irritation, blockage of blood vessels, or a systemic immune response.
Refund and medical consultation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.